ABSTRACT: The recent development of poly(dopamine) (PDA) capsules provides new opportunities for their application in biology and medicine. To advance the biomedical application of PDA capsules, strategies that enable the preparation of fluorescently labeled PDA (F-PDA) capsules are required, as this will allow evaluation of their cellular interactions using a range of fluorescence-based techniques. Herein, we report a facile approach for the fabrication of F-PDA capsules via the polymerization of dopamine (DA) on sacrificial templates in the presence of hydrogen peroxide (H 2 O 2 ). F-PDA capsules with well-defined sizes are prepared by templating different organic and inorganic particles. The resulting F-PDA capsules show negligible cytotoxicity in HeLa cells after incubation for 48 h. We also demonstrate visualization of the F-PDA capsules following internalization by HeLa cells using conventional fluorescence microscopy, en route toward detailed investigations on their biological interactions.
INTRODUCTION
Poly(dopamine) (PDA), formed by the oxidative polymerization of dopamine (DA), is a wellknown melanin-like biopolymer in many parts of living organisms. 1 By mimicking mussel protein adhesion, Messersmith and co-workers pioneered a simple but versatile surface modification approach based on DA polymerization in alkaline solution onto various organic and inorganic substrates, including noble metals, oxides, polymers, semiconductors, and ceramics. 2 The obtained PDA surface coating is reactive to amine and thiol groups via Schiff base formation or Michael addition, which provides a facile approach to modify surfaces with various functional molecules. 3 Alternatively, functional molecules can be incorporated into the PDA structure during the polymerization process, allowing the fabrication of hybrid coatings with diverse reactivity and physicochemical properties. 4 The advantage of PDA coatings reside in their versatility, such as control over their thickness, surface chemistry, and excellent biocompatibility, 5 PDA-based polymer capsules have recently been prepared by templated assembly which represents an attractive approach for engineering nanostructures. 6 A number of particulate templates have been used, including porous 7 and nonporous 8 silica particles, and emulsion droplets. 9 Recently, biological studies of these PDA capsules have been reported; for example, submicrometer-sized PDA capsules have been used to immobilize doxorubicin via a pH-liable linker, and these drug-loaded PDA capsules show effective intracellular drug release in cancer cells in vitro. 10 The ability to track the mobility of PDA capsules in biological systems will provide important insights into their safety and efficacy as drug carriers. However, PDA is known to act as a fluorescence quencher, which complicates the fluorescent labeling of PDA capsules. GlutaMAX supplement (Gibco) containing 10% fetal bovine serum at 37 °C in a 5% CO 2 humidified atmosphere and subcultured prior to confluence using trypsin.
MTT Assay. HeLa cells were seeded at a density of 2 x 10 4 cells per well in 96-well plates.
Cells were incubated for 48 h at 37 °C in a 5% CO 2 was determined by TEM to be 60 ± 10 nm (inset, Figure 2B ). It is noted that an F-PDA layer can be formed directly on the pristine template particles without the first PDA coating; however, without the first PDA coating, the resulting capsules exhibited poor mechanical strength, and did not yield stable free-standing capsules after template removal. In addition, in the case of SiO 2 templates, treatment with HF for template removal resulted in a significant decrease in the fluorescence intensity of the F-PDA capsules compared with the F-PDA core-shell particles ( Figure S2 ). Based on these two findings, we prepared F-PDA capsules by forming the fluorescent coating on preformed PDA capsules, as illustrated in Scheme 1. Fluorescence Properties of F-PDA Capsules. To identify the optimum excitation wavelength of the F-PDA capsules, UV-Vis absorption spectra of the F-PDA capsules were measured. F-PDA capsules exhibited a broad absorption, from 350-600 nm ( Figure S3 ). The underlying broad absorption (350-600 nm) is expected due to the presence of PDA in the capsule walls. A broad monotonic absorption spectra is characteristic of PDA 15 and synthetic melanins, 16 although the exact reason for this unique absorption behavior is debated in literature. [16] [17] Additionally, the UV-vis absorption spectra also exhibited a shoulder at 350-400 nm, which can be attributed to the presence of fluorescent species formed in solution, which are incorporated (either covalently or non-covalently) into the PDA films during the oxidative treatment process. Excitation of a suspension of F-PDA capsules at 400 nm results in fluorescence emission at ca. 480 nm.
Moreover, the supernatant of the F-PDA coating process is also found to exhibit strong fluorescence at 480 nm when excited at 400 nm ( Figure S4 ). In a control experiment, PDA The F-PDA capsules were incubated with HeLa cells for 24 h, and the cells were fixed after the treatment. Subsequently, the cell membranes and nuclei were stained with fluorescent probes. By using a fluorescence deconvolution microscopy with a standard TRITC filter (excitation of 555 ± 14 nm, emission of 617 ± 37 nm), the F-PDA capsules were imaged, showing as spherical structures ( Figure 5 ). Importantly, based on the cell membrane staining, the F-PDA capsules were found to be effectively internalized by HeLa cells ( Figure 5B ). It is noted that in contrast to many multilayered polymer capsules, these internalized F-PDA capsules retained the spherical morphology, showing little deformation. This is presumably due to the thicker F-PDA capsule shell (~60 nm) observed by TEM, leading to increased mechanical strength. The effective internalization of F-PDA capsules is also consistent with our previous report on the pH-triggered endocytic drug release using PDA capsules, although the two capsules possess some differences in their physicochemical properties. 10 In addition, there has been considerable interest to engineer degradable PDA drug carriers based on biological cues, such as enzymes. 19 The cell membrane was stained with AF488-labeled wheat germ agglutinin (green), and the nuclei were stained with Hoechst 33342 (blue).
CONCLUSION
We have reported the synthesis of F-PDA capsules with well-defined sizes via the polymerization of DA in the presence of H 2 O 2 . The resulting fluorescence of F-PDA capsules were shown to be pH-dependent, with the highest fluorescence intensity observed at pH 3. In addition, the F-PDA capsules (1.1 μm diameter) showed negligible cytotoxicity in HeLa cells after incubation for 48 h at various doses. The internalized F-PDA capsules in HeLa cells were found to be readily visualized using conventional fluorescence microscopy, which allows further quantitative and qualitative analysis of the cellular interactions of PDA materials. This information will be valuable for the developments of PDA in various biological applications.
Given the diversity of templates, it is expected that F-PDA capsules with different morphologies can also be fabricated through this versatile approach.
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